Influence of a Residential Rehabilitation Program on Body Composition in Patients With Cystic Fibrosis

December 15, 2022 updated by: University Hospital, Ghent

Influence of a Residential Rehabilitation Program on Body Composition in Patients With Cystic Fibrosis (Children and Adults)

The aim is to evaluate the impact of a 3-week lasting residential rehabilitation program for patients with cystic fibrosis on their nutritional status measured as BMI and body composition and pulmonary function.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Detailed Description

Cystic fibrosis Patients following a residential rehabilitation program consisting of dietary adaptation, physical therapy for airway drainage and supervised inhalation therapy and physical activity for at least 3 weeks are asked to participate. Weight, height, body composition and pulmonary function will be measured at start and end of the program. Dietary intake during the program is calculated based on a 2 day weighed intake diary and physical activity will be measured with the "SenseWear pro 3" armband.

Study Type

Observational

Enrollment (Actual)

39

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • De Haan, Belgium, 8420
        • Zeepreventorium de Haan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients With Cystic Fibrosis

Description

Inclusion Criteria:

  • Cystic fibrosis
  • stay at the rehabilitation center for at least 3 consecutive weeks

Exclusion Criteria:

  • steroid use
  • absence from the program for more than 2 consecutive days

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
rehabilitation
All included patients get an pre-intervention and a post intervention analysis

During the rehabilitation program a multidisciplinary team, consisting of a pneumologist, dietician, psychologist, social worker and several physiotherapists, coach the cystic fibrosis patients.

The physiotherapists help with autogenic drainage and aerosol therapy (2-3 times/day) and supervise physical activity (5, 1-hour lasting, training sessions/week: swimming 2, Fitness training 2, 1 session of choice). The dietician calculates basal and theoretical energy needs . A carbohydrate-rich snack before exercise, to improve exercise tolerance and a carbohydrate-protein-rich snack afterwards to improve recuperation is provided.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
body composition change
Time Frame: day 0 and day 21 (start and end of the rehabilitation program)
Dual energy X-ray absorptiometry measured Fat mass index (kg/m*2)
day 0 and day 21 (start and end of the rehabilitation program)
body composition change
Time Frame: day 0 and day 21 (start and end of the rehabilitation program)
Dual energy X-ray absorptiometry measured fat free mass (kg/m*2)
day 0 and day 21 (start and end of the rehabilitation program)
Body mass index change
Time Frame: day 0 and day 21 (start and end of the rehabilitation program)
calculated based on weight and height (kg/m*2) converted in standard deviations
day 0 and day 21 (start and end of the rehabilitation program)
Weight change
Time Frame: day 0 and day 21 (start and end of the rehabilitation program)
Scale weighed weight (kg) converted in standard deviations of normal population of normal populations
day 0 and day 21 (start and end of the rehabilitation program)
pulmonary function change
Time Frame: day 0 and day 21 (start and end of the rehabilitation program)
forced expiratory volume in 1 second (% of normal)
day 0 and day 21 (start and end of the rehabilitation program)
pulmonary function change
Time Frame: day 0 and day 21 (start and end of the rehabilitation program)
Forced Vital capacity (% of normal)
day 0 and day 21 (start and end of the rehabilitation program)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity
Time Frame: Week 1
"SenseWear pro 3" armband measured physical activity
Week 1
dietary intake
Time Frame: 2 days/week for 3 consecutive weeks
macronutrient intake measured based on 2 days/week weighed nutritional intake
2 days/week for 3 consecutive weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephanie Van Biervliet, MD, PhD, Gent University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2018

Primary Completion (Actual)

May 1, 2020

Study Completion (Actual)

July 1, 2020

Study Registration Dates

First Submitted

August 19, 2020

First Submitted That Met QC Criteria

August 25, 2020

First Posted (Actual)

August 27, 2020

Study Record Updates

Last Update Posted (Estimate)

December 20, 2022

Last Update Submitted That Met QC Criteria

December 15, 2022

Last Verified

August 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cystic Fibrosis

Clinical Trials on Rehabilitation

3
Subscribe